2m 2m 2m 2m 2m 2m 2m
VERRICA PHARMA (VRCA)
NASDAQ
$5.89+$0.10 (+1.73%)
Price as of Jun 03, 2026 4:10 PM EDT- $98.9MMarket Cap
- 9.02%1-Year Change
- BiotechnologyIndustry
VERRICA PHARMA (VRCA)
$5.89+$0.10 (+1.73%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 15.3M +102.02% | 7.6M +47.66% | 5.1M -43.27% | 9.0M -24.73% | |
Cost of Revenue | N/A N/A | 2.6M +420.00% | 500,000 N/A | N/A N/A | |
Gross Profit | 15.3M +207.79% | 5.0M +7.40% | 4.6M -48.80% | 9.0M -24.73% | |
Sales and Marketing Expense | 35.2M -40.12% | 58.8M +24.35% | 47.3M N/A | N/A N/A | |
Research and Development Expense | -8.9M -25.21% | -11.8M -41.66% | -20.3M +66.38% | -12.2M -23.42% | |
Depreciation and Amortization Expense | 133,000 -61.11% | 342,000 -35.47% | 530,000 +16.74% | 454,000 +86.07% | |
Total Operating Expenses | 47.8M -35.00% | 73.5M +3.67% | 70.9M +133.72% | 30.3M -29.32% | |
Operating Profit | -12.2M -81.52% | -65.9M +0.24% | -65.8M +208.79% | -21.3M -31.10% | |
Interest Income | 929,000 -34.44% | 1.4M -48.28% | 2.7M +475.63% | 476,000 +286.99% | |
Interest Expense | -7.5M -18.48% | -9.2M +132.21% | -4.0M +82.41% | -2.2M -49.43% | |
Interest Income and Expense and Net | -6.6M -15.57% | -7.8M +536.91% | -1.2M -27.95% | -1.7M -59.35% | |
Total Nonoperating Income and Expense | -5.7M -46.52% | -10.7M +762.46% | -1.2M -61.27% | -3.2M -23.51% | |
Income before Taxes | -12.2M -81.52% | -65.9M +0.24% | -65.8M +208.79% | -21.3M -31.10% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -17.9M -76.64% | -76.6M +14.31% | -67.0M +173.59% | -24.5M -30.20% | |
Net Income from Continuing Operations Applicable to Common | -17.9M -76.64% | -76.6M +14.31% | -67.0M +173.59% | -24.5M -30.20% | |
Basic EPS and Net Income | -1.68 +13.51% | -1.48 0.00% | -1.48 +105.56% | -0.72 -44.62% | |
Diluted EPS and Net Income | -1.68 +13.51% | -1.48 0.00% | -1.48 +105.56% | -0.72 -44.62% | |
Basic Weighted Average Shares | 10.7M -79.44% | 51.8M +14.26% | 45.3M +32.72% | 34.2M +26.32% | |
Diluted Weighted Average Shares | 10.7M -79.44% | 51.8M +14.26% | 45.3M +32.72% | 34.2M +26.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 30.1M -34.93% | 46.3M -33.38% | 69.5M +102.92% | 34.3M +117.58% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Cash and Cash Equivalents and Short-Term Investments | 30.1M -34.93% | 46.3M -33.38% | 69.5M +102.92% | 34.3M +117.58% | |
Total Current Assets | 42.5M -16.88% | 51.2M -33.99% | 77.5M +98.21% | 39.1M -47.38% | |
Accumulated Depreciation | 1.1M -16.53% | 1.3M +7.16% | 1.2M +67.95% | 699,000 +175.20% | |
Property and Plant and Equipment and Net | 209,000 -64.52% | 589,000 -44.01% | 1.1M -72.94% | 3.9M -0.18% | |
Total Long-Term Assets | 376,000 0.00% | 376,000 -16.81% | 452,000 +63.77% | 276,000 -6.44% | |
Total Assets | 47.1M -12.94% | 54.1M -33.66% | 81.6M +82.46% | 44.7M -44.19% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 12.9M -90.94% | 142.9M N/A | 0 -100.00% | |
Total Current Liabilities | 16.4M -43.34% | 29.0M +70.42% | 17.0M +392.17% | 3.5M -92.49% | |
Total Long-Term Debt | 0 -100.00% | 31.0M -27.73% | 42.9M N/A | N/A N/A | |
Total Long-Term Liabilities | 242,000 -99.29% | 34.2M -21.86% | 43.8M +3,462.57% | 1.2M -15.18% | |
Total Liabilities | 22.4M -65.02% | 64.0M +3.49% | 61.8M +1,218.98% | 4.7M -90.13% | |
Retained Earnings | -324.9M +5.83% | -307.0M +33.23% | -230.4M +40.99% | -163.5M +17.62% | |
Total Stockholders Equity | 24.7M +350.94% | -9.9M -149.89% | 19.8M -50.63% | 40.0M +22.78% | |
Total Shares Outstanding | 17.2M -81.28% | 91.8M +116.39% | 42.4M +3.21% | 41.1M +49.33% | |
Cash Flow | |||||
Cash from Operating Activities | -17.6M -71.07% | -60.9M +57.94% | -38.6M +106.85% | -18.6M -32.38% | |
Capital Expenditures | 0 -100.00% | 27,000 -92.54% | 362,000 +19.87% | 302,000 -65.80% | |
Cash from Investing Activities | 0 +100.00% | -19,000 -94.75% | -362,000 -100.67% | 54.0M +5,514.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.4M -96.17% | 37.7M -49.16% | 74.2M +539.91% | -16.9M -150.14% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 65.64% -27.27% | 90.24% N/A | N/A N/A | |
Operating Margin | -79.72% -90.85% | -871.25% -32.11% | -1,283.35% +444.29% | -235.78% -8.46% | |
Return on Assets | -35.33% -68.69% | -112.84% +6.38% | -106.07% +170.41% | -39.23% -13.74% | |
Return on Equity | -240.35% -84.46% | -1,546.58% +590.20% | -224.08% +232.35% | -67.42% -36.97% | |
Revenue Growth | 102.02% +114.07% | 47.66% +210.15% | -43.27% +74.94% | -24.73% N/A | |
Current Ratio | 2.59 +46.70% | 1.76 -61.26% | 4.55 -59.73% | 11.31 +600.68% | |
Cash Ratio | 1.83 +14.85% | 1.60 -60.91% | 4.09 -58.77% | 9.91 +2,797.19% | |
Debt-to-Equity Ratio | 0.00 +100.00% | -4.45 -147.39% | 9.40 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.00 -100.00% | 0.81 -64.36% | 2.28 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow